In the 1990s, genetic evaluation of BCCs of patients with GS revealed the most crucial discovery in BCC research history: BCC lesions are often linked to mutations in the patched1 (PTCH1) gene loci [54,55,56,57]. Here, PTCH1 is linked to skin basal cell carcinoma.